Gunjan OHRI - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Gunjan OHRI's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Gunjan OHRI
Verified
Data Content Analyst, BioCentury
Claremont
Beats
running, running training, programs, nutrition for runners, gear for runners
Content
By Gunjan OHRI| BioCentury Verified DATA GRAPHICS | Data ByteLilly to seek re-examination. Also in March meeting, CHMP backs label expansions for Opdivo, Tevimbra and more By Gunjan Ohri, Data Content Analyst, and Selina Koch, Executive EditorDue to safety concerns, EMA’s CHMP has recommended against approval of Kisunla donanemab to treat early Alzheimer’s disease, even in patients with no copies of the risk allele APOE4.
By Gunjan OHRI| BioCentury Verified ARTICLE | Management TracksPlus: Scott Gottlieb named chair of Illumina, and updates from Syncromune and OSR By Gunjan Ohri, Data Content AnalystBarclay Butler was named deputy commissioner for operations and chief operating officer in the office of operations at FDA. Butler held various roles at the Defense Health Agency, including as assistant director for support, management and healthcare administration. He was most recently an independent consultant at Barclay Consulting Services.
By Gunjan OHRI| BioCentury Verified DATA GRAPHICS | Data ByteLilly to seek re-examination. Also in March meeting, CHMP backs label expansions for Opdivo, Tevimbra and more By Gunjan Ohri, Data Content Analyst, and Selina Koch, Executive EditorDue to safety concerns, EMA’s CHMP has recommended against approval of Kisunla donanemab to treat early Alzheimer’s disease, even in patients with no copies of the risk allele APOE4.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
Chicago, United States
+1 650-595-5333
Founded: 1992